Clinical Trial Update: Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy [NA]

View source ↗

Summary

A completed clinical trial evaluated cyclosporine therapy for reversal of epidermal phenotype in severe atopic dermatitis. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Rockefeller University | Conditions: Atopic Dermatitis, Eczema | NA | Status: COMPLETED | Results posted: 2017-03-27